Ribozymes as Human Therapeutic Agents

Journal of Medicinal Chemistry

Volumn 38, Issue 12, 1995, Pages 2023-2037

  Christoffersen, Ralph E ^a   Marr, J Joseph ^a  

^a Sirna Therapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; COMPLEMENTARY RNA; MESSENGER RNA; OLIGONUCLEOTIDE; RIBOZYME; VIRUS VECTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; CANCER; CANCER INHIBITION; DIAGNOSTIC VALUE; DRUG MECHANISM; DRUG SELECTIVITY; ENZYME ACTIVITY; GENE EXPRESSION; GENE THERAPY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOLECULAR GENETICS; NONHUMAN; ONCOGENE; PHARMACOGENETICS; REVIEW; RNA SPLICING; TRANSGENIC ANIMAL; TUMOR SUPPRESSOR GENE; VIRUS INFECTION; VIRUS INHIBITION;

ANIMAL; BASE SEQUENCE; DRUG DESIGN; HUMAN; MOLECULAR SEQUENCE DATA; RNA, CATALYTIC;

EID: 0029042615     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00012a001     Document Type: Article

References (131)

1. Cech, T. R.; Zaug, A. J.; Grabowski, P. J. In vitro Splicing of the Ribosomal RNA Precursor of Tetrahymena: Involvement of a Guanosine Nucleotide in the Excision of the Intervening Sequence. Cell 1981, 29, 487-496.
2. Kruger, K.; Grabowski, P. J.; Zaug, A. J.; Sands, J.; Gottschling, D. F.; Cech, T. R. Self-splicing RNA: Autoexcision and Autocy-clization of the Ribosomal RNA Intervening Sequence of Tetrahymena. Cell 1982, 31, 147-157.
3. Guerrier-Takada, C.; Gardiner, K.; Marsh, T.; Pace, N.; Altman, S. The RNA Moiety of Ribonuclease P Is the Catalytic Subunit of the Enzyme. Cell 1983, 35, 849-857.
4. Cech, T. R. Self-splicing RNA: Implications for Evolution. Int. Rev. Cytol. 1985, 93, 3-22.
5. Darnell, J. S.; Doolittle, W. F. Speculations on the Early Course of Evolution. Proc. Natl. Acad. Sci. U. SA. 1986, 83, 1271-1275.
6. Cech, T. R. A Model for the RNA-catalyzed Replication of RNA. Proc. Natl. Acad. Sci. U. SA. 1986, 83, 4360-4363.
7. Joyce, G. F.; Schwartz, A. W.; Miller, S. L.; Orgel, L. E. The Case for An Ancestral Genetic System Involving Simple Analogues of the Nucleotides. Proc. Natl. Acad. Sci. U. SA. 1987, 84, 4398-4402.
8. Cech, T. R. RNA Chemistry. Ribozyme Self-replication? Nature 1989, 339, 507-508.
9. Doudna, J. A.; Szostak, J. W. RNA-catalyzed Synthesis of Complementary-strand RNA. Nature 1989, 339, 519-522.
10. Cech, T. R. The Efficiency and Versatility of Catalytic RNA: Implications for An RNA World. Gene 1993, 135, 33-36.
11. Cech, T. R. Ribozyme Engineering. Curr. Opin. Struct. Biol. 1992, 2, 605-609.
12. Cech, T. R. The Generality of Self-splicing RNA: Relationship to Nuclear mRNA Splicing. Cell 1986, 44, 207-210.
13. Peebles, C. L.; Perlman, P. S.; Mecklinburg, K. L.; Petrillo, M. L.; Tabor, J. H.; Jarrell, K. A.; Cheng, H.-L. A Self-splicing RNA Excises an Intron Lariat. Cell 1986, 44, 213-223.
14. Van der Veen, R. T.; Arnberg, A. C.; Van der Horst, G.; Bonen, L.; Tabak, H. F.; Grivell, L. A. Excised Group II Introns in Yeast Mitochondria Are Lariats And Can Be Formed By Self-splicing In Vitro. Cell 1986, 44, 225-234.
15. Michel, F.; Umesono, K.; Ozeki, H. Comparative and Functional Anatomy of Group II Catalytic Introns - A Review. Gene 1989, 82, 5-30.
16. Zaug, A. J.; Kent, J. R.; Cech, T. R. A Labile Phosphodiester Bond at the Ligation Junction in A Circular Intervening Sequence. Science 1984, 224, 574-578.
17. Zaug, A. J.; Cech, T. R. The Intervening Sequence RNA of Tetrahymena Is An Enzyme. Science 1986, 231, 470-475.
18. Zaug, A. J.; Been, M. D.; Cech, T. R. The Tetrahymena Ribozyme Acts Like An RNA Restriction Endonuclease. Nature 1986, 324, 429-433.
19. Xu, M.-Q.; Kathe, S. D.; Goodrich-Blair, H.; Nierzwicki-Bauer, S. A.; Shub, D. A. Bacterial Origin of Chloroplast Intron: Conserved Self-Splicing Group I Introns in Cyanobacteria. Science 1990, 250, 1566-1570.
20. Johansen, S.; Vogt, V. M. An Intron in the Nuclear Ribosomal DNA of Didymium iridis Codes for a Group I Ribozyme and a Novel Ribozyme That Cooperate in Self-Splicing. Cell 1994, 76, 725-734.
21. Guo, H. C. T.; Collins, R. A. Efficient trans-cleavage of a stem-loop RNA substrate by a ribozyme derived from Neurospora VS RNA. EMBO J. 1995, 14, 368-376.
22. Prody, G. A.; Bakos, J. T.; Buzayan, J. M.; Schneider, I. R.; Bruening, G. Autolytic Processing of Dimeric Plant Virus Satellite RNA. Science 1986, 231, 1577-1580.
23. Hutchins, C. J.; Rathjen, P. D.; Forster, A. C.; Symons, R. H. Self-cleavage of Plus And Minus RNA Transcripts of Avocado Sunblotch Viroid. Nucl. Acids Res. 1986, 14, 3627-3640.
24. Uhlenbeck, O. C. A Small Catalytic Oligoribonucleotide. Nature 1987, 328, 596-600.
25. Forster, A. C.; Symons, R. H. Self-cleavage of Virusoid RNA Is Performed By The Proposed 55-Nucleotide Active Site. Cell 1987, 50, 9-16.
26. Edington, B. V.; Nelson, R. S. Utilization or Ribozymes in Plants. Gene Regulation′. Biology of Antisense RNA and DNA. Erickson, R. P., Izant, J. G., Eds.; Raven Press: New York, 1992; pp 209-221.
27. Sharmeen, L.; Kuo, M. Y. P.; Dinter-Gottlieb, G.; Taylor, J. Antigenomic RNA of Human Hepatitis Delta Virus Can Undergo Self-Cleavage. J. Virol. 1988, 62, 2674-2679.
28. Wu, H.-N.; Lin, Y.-J.; Lin, F.-P.; Makino, S.; Chang, M.-F.; Lai, M. M. C. Human Hepatitis Delta Virus RNA Subfragments Contain An Autocleavage Activity. Proc. Natl. Acad. Sci. U. SA. 1989, 86, 1831-1835.
29. Haseloff, J.; Gerlach, W. L. Simple RNA Enzymes with New and Highly Specific Endoribonuclease Activities. Nature 1988, 334, 585-591.
30. Hampel, A.; Tritz, R.; Hicks, M.; Cruz, P. “Hairpin” Catalytic RNA Model: Evidence for Helices and Sequence Requirement for Substrate RNA. Nucl. Acids Res. 1990, 18, 299-304.
31. Feldstein, P. A.; Buzayan, J. M.; Bruening, G. Two Sequences Participating in the Autolytic Processing of Satellite Tobacco Ringspot Virus Complementary RNA. Gene 1989, 82, 53-61.
32. Perrotta, A. T.; Been, M. D. A Pseudoknot-Like Structure Required for Efficient Self-Cleavage of Hepatitis Delta Virus RNA. Nature 1991, 350, 434-436.
33. Branch, A. D.; Robertson, H. D. Efficient Trans Cleavage and A Common Structural Motif for the Ribozymes of the Human Hepatitis Delta Agent. Proc. Natl. Acad. Sci. U. SA. 1991, 88, 10163-10167.
34. Perrotta, A. T.; Been, M. D. Cleavage of Oligoribonucleotides By A Ribozyme Derived from the Hepatitis Delta Virus RNA Sequence. Biochemistry 1992, 31, 16-21.
35. Helene, C.; Toulme, J. J. Specific Regulation of Gene Expression by Antisense, Sense, and Antigene Nucleic Acids. Biochim. Biophys. Acta 1990, 1049, 99-125.
36. Hearst, J. E. A Photochemical Investigation of the Dynamics of Oligonucleotide Hybridization. Annu. Rev. Phys. Chem. 1988, 39, 291-315.
37. Herschlag, D. Implications of Ribozyme Kinetics for Targeting the Cleavage of Specific RNA Molecules in Vivo; More Isn’t Always Better. Proc. Natl. Acad. Sci. U. SA. 1991, 88, 6921-6925.
38. Young, B.; Herschlag, D.; Cech, T. R. Mutations in a Nonconserved Sequence of the Tetrahymena Ribozyme Increase Activity and Specificity. Cell 1991, 67, 1007-1019.
39. Beaudry, A. A.; Joyce, G. F. Directed Evolution of an RNA Enzyme. Science 1992, 257, 635-641.
40. Green, R.; Szostak, J. W. Selection of a Ribozyme that Functions as a Superior Template in a Self-Copying Reaction. Science 1992, 258, 1910-1915.
41. Lehman, N.; Joyce, G. F. Evolution In Vitro of an RNA Enzyme with Altered Metal Dependence. Nature 1993, 361, 182-185.
42. 2′. Biochemistry 1992, 31, 3887-3895.
43. Bartel, D. P.; Szostak, J. W. Isolation of New Ribozymes from a Large Pool of Random Sequences. Science 1993, 261, 1411-1418.
44. Prudent, J. R.; Uno, T.; Schultz, P. G. Expanding the Scope of RNA Catalysis. Science 1994, 264, 1924-1927.
45. Lorsch, J. R.; Szostak, J. W. In vitro Evolution of New Ribozymes with Polynucleotide Kinase Activity. Nature 1994, 371, 31-36.
46. Cameron, F. H.; Jennings, P. A. Specific Gene Suppression by Engineered Ribozymes in Monkey Cells. Proc. Natl. Acad. Sci. U. SA. 1989, 86, 9139-9143.
47. Cotten, M.; Bimstiel, M. L. Ribozyme Mediated Destruction of RNA in vivo. EMBO J. 1989, 8, 3861-3866.
48. L’Huillier, P. J.; Davis, S. R.; Bellamy, A. R. Cytoplasmic Delivery of Ribozymes Leads to Efficient Reduction in α-lactalbumin mRNA Levels in C1271 Mouse Cells. EMBO J. 1992, 11, 4411-4418.
49. Saxena, S. K.; Ackerman, E. J. Ribozymes Correctly Cleave a Model Substrate and Endogenous RNA In Vivo. J. Biol. Chem. 1990, 265, 17106-17109.
50. Inokuchi, Y.; Yuyama, N.; Hirashima, A.; Nishikawa, S.; Ohkawa, J.; Taira, J. A Hammerhead Ribozyme Inhibits the Proliferation of an RNA Coliphage SP in E. Coli. J. Biol. Chem. 1994, 269, 11361-11366.
51. Efrat, S.; Leiser, M.; Wu, Y.-J.; Fusco-DeMane, D.; Emran, O. A.; Surana, M.; Jetton, T. L.; Magnuson, M. A.; Weir, G.; Fleischer, N. Ribozyme-Mediated Attenuation of Pancreatic (3-Cell Glucokinase Expression in Transgenic Mice Results in Impaired Glucose-Induced Insulin Secretion. Proc. Natl. Acad. Sci. U. SA. 1994, 91, 2051-2055.
52. Steinecke, P.; Herget, T.; Schreier, P. H. Expression of a Chimeric Ribozyme Gene Results in Endonucleolytic Cleavage of Target mRNA and A Concomitant Reduction of Gene Expression In Vivo. EMBO J. 1992, 11, 1525-1530.
53. Zhao, J. J.; Pick, L. Generating Loss-of-function Phenotypes of the fushi tarazu Gene with a Targeted Ribozyme in Drosophila. Nature 1993, 365, 448-451.
54. Larsson, S.; Hotchkiss, G.; Andang, M.; Nyholm, T.; Inzumza, J.; Jansson, I.; Ahrlund-Richter, L. Reduced β2-microglobulin mRNA Levels in Transgenic Mice Expressing a Designed Hammerhead Ribozyme. Nucl. Acids Res. 1994, 22, 2242-2248.
55. Zuker, M. On Finding All Suboptimal Foldings of an RNA Molecule Science 1989, 244, 48-52.
56. Christoffersen, R. E.; McSwiggen, J. A.; Konings, D. Application of Computational Technologies to Ribozyme Biotechnology Products. J. Mol. Struct. (THEOCHEM) 1994, 311, 273-284.
57. Beaucage, S. L.; Iyer, R. P. The Functionalization of Oligonucleotides via Phosphoramidite Derivatives. Tetrahedron 1993, 49, 6123-6194.
58. Milligan, J. F.; Matteucci, M. D.; Martin, J. C. Current Concepts in Antisense Drug Design. J. Med. Chem. 1993, 36, 1923-1937.
59. Pieken, W. A.; Olsen, D. B.; Benseler, F.; Aurup, H.; Eckstein, F. Kinetic Characterization of Ribonuclease Resistant 2′-modified Hammerhead Ribozymes. Science 1991, 253, 314-317.
60. Scaringe, S. A.; Franklyn, C.; Usman, N. Chemical Synthesis of Biologically Active Oligoribonucleotides Using β-cyanoethyl Protected Ribonucloside Phosphoramidites. Nucl. Acids Res. 1990, 18, 5433-5441.
61. Yang, J.-H.; Usman, N.; Chartrand, P.; Cedergren, R. J. Minimum Ribonucleotide Requirement for Catalysis by the RNA Hammerhead Domain. Biochemistry 1992, 31, 5005-5009.
62. Paolella, G.; Sproat, B. S.; Lamond, A. I. Nuclease-resistant Ribozymes with High Catalytic Activity. EMBO J. 1992, 11, 1913-1919.
63. Shibahara, S.; Mukai, S.; Morisawa, H.; Nakashima, H.; Kobayashi, S.; Yamamoto, N. Inhibition of Human Immunodeficiency Virus (HIV-1) Replication by Synthetic Oligo-RNA Derivatives. Nucl. Acids Res. 1989, 17, 239-252.
64. Beigelman, L.; Karpeisky, A.; Usman, N. Synthesis of 1-Deoxy-D-Ribofuranose Phosphoramidite and the Incorporation of Abasic Nucleotides in Stem-Loop II of a Hammerhead Ribozyme. Bioorg. Med. Chem. Lett. 1994, 4, 1715-1720.
65. Usman, N.; Beigelman, L.; Draper, K.; Gonzalez, C.; Jensen, K.; Karpeisky, A.; Modak, A.; Matulic-Adamic, J.; DiRenzo, A.; Haeberli, P.; Tracz, D.; Grimm, S.; Wincott, F.; McSwiggen, J. Chemical Modification of Hammerhead Ribozymes: Activity and Nuclease Resistance. Biochemistry, in press.
66. Lichtenberg, D.; Liposomes: Preparation, Characterization, and Preservation. Methods Biochem. Anal. 1988, 33, 337-468.
67. Litzinger, D. C.; Huang, L. Phosphatidylethanolamine Liposomes: Drug Delivery, Gene Transfer and Immunodiagnostic Applications. Biochim. Biophys. Acta 1992, 1113, 201-227.
68. Mayer, L. D.; Tai, L. C. L.; Ko, D. S. C.; Masin, D.; Ginsberg, R. S.; Cullis, P. R.; Bally, M. B. Influence of Vesicle Size, Lipid Composition, and Drug-to-Lipid Ratio on the Biological Activity of Liposomal Doxorubicin in Mice. Cancer Res. 1989, 49, 5922-5930.
69. Litzinger, D. C.; Huang, L. Biodistribution and Immunotarget- ability of Ganglioside-Stabiiized Dioleoylphosphatidylethanolamine Liposomes. Biochim. Biophys. Acta 1992, 1104, 179-187.
70. Leserman, L. D.; Weinstein, J. N.; Blumenthal, R.; Terry, W. D. Receptor-mediated Endocytosis of antibody-opsonized liposomes by tumor cells. Proc. Natl. Acad. Sci. U. SA. 1980, 77, 4089-4093.
71. Berinstein, N.; Matthay, K. K.; Papahadjopoulos, D.; Levy, R.; Sikic, B. I. Antibody-Directed Targeting of Liposomes to Human Cell Lines: Role of Binding and Internalization of Growth Inhibition. Cancer Res. 1987, 47, 5954-5959.
72. Milhaud, P. G.; Machy, P.; Lebleu, B.; Leserman, L. Antibody-targeted Liposomes Containing poly (rl)-poly (rC) Exert a Specific Antiviral and Toxic Effect on Cells Primed with Interferons a/β or γ. Biochim. Biophys. Acta 1989, 987, 15-20.
73. Moghimi, S. M.; Patel, H. M. Opsonophagocytosis of Liposomes by Peritoneal Macrophages and Bone Marrow Reticulendothelial Cells. Biochim. Biophys. Acta 1992, 1135, 269-274.
74. Papahadjopoulos, D.; Allen, T. M.; Gabizon, A.; Mayhew, E.; Matthay, K.; Huang, S. K.; Lee, K.-D.; Woodle, M. C.; Lasic, D. D.; Redemann, C.; Martin, F. J. Sterically stabilized liposomes: Pronounced improvmenets in blood clearance, tissue distribution and therapeutic index of encapsulated drugs against implanted tumors. Proc. Natl. Acad. Sci. U. SA. 1991, 88, 11460-11464.
75. Klibanov, A. L.; Maruyama, K.; Beckerleg, A. M.; Torchilin, V. P.; Huang, L. Activity of amphipathic poly (ethylene glycol) 5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target. Biochim. Biophys. Acta 1991, 1062, 142-148.
76. Lee, R. J.; Low, P. S. Delivery of Liposomes into Cultured KB Cells via Folate Receptor-mediated Endocytosis. J. Biol. Chem. 1994, 269, 3198-3204.
77. Nabel, E. G.; Plautz, G.; Boyce, F. M.; Stanley, J. C.; Nabel, G. J. Recombinant gene expression in vivo within endothelial cells of the arterial wall. Science 1989, 244, 1342-1344.
78. Nabel, E. G.; Plautz, G.; Nabel, G. J. Site-specific Gene Expression In Vivo By Direct Gene Transfer into the Arterial Wall. Science 1990, 249, 1285-1288.
79. Nabel, G. J.; Nabel, E. G.; Yang, Z.-Y.; Fox, B. A.; Plautz, G. E.; Gao, X.; Huang, L.; Shu, S.; Gordon, D.; Chang, A. E. Direct Gene Transfer with DNA Liposome Complexes in Melanoma: Expression, Biologic Activity and Lack of Toxicity in Humans. Proc. Natl. Acad. Sci. U. SA. 1993, 90, 11307-11311.
80. Plautz, G. E.; Yang, Z.; Wu, B.; Gao, X.; Huang, L.; Nabel, G. J. Immunotherapy of malignancy by in vivo gene transfer into tumors. Proc. Natl. Acad. Sci., U. SA. 1993, 90, 4645-4649.
81. Stewart, M. J.; Plautz, G. E.; Del Buono, L.; Yang, Z. Y.; Xu, L.; Gao, X.; Huang, L.; Nabel, E. G.; Nabel, G. J. Gene Transfer in Vivo with DAN-liposome Complexes: Safety and Acute Toxicity in Mice. Human Gene Ther. 1992, 3, 267-275.
82. Zhu, N.; Liggitt, D.; Liu, Y.; Debs, R. Systemic Gene Expression after Intravenous DNA Delivery into Adult Mice. Science 1993, 261, 209-211.
83. San, H.; Yang, Z.-H.; Pompili, V. J.; Jaffe, M. L.; Plautz, G. E.; Xu, L.; Feigner, J. H.; Wheeler, C. J.; Feigner, P. L.; Gao, X.; Huang, L.; Gordon, D.; Nabel, G. J.; Nabel, E. G. Safety and Short-Term Toxicity of a Novel Cationic Lipid Formulation for Human Gene Therapy. Human Gene Ther. 1993, 4, 781-788.
84. Plautz, G. E.; Wu, B.-Y.; Gao, X.; Huang, L.; Nabel, G. J. Gene Transfer In Vivo with DNA-liposome Complexes: Lack of Autoimmunity and Gonadal Localization. Human Gene Ther. 1992a, 3, 649-656.
85. Sullenger, B. A.; Cech, T. R. Tethering Ribozymes to a Retroviral packaging Signal for Destruction of Viral RNA. Science 1993, 262, 1566-1569.
86. Tsuchihashi, A.; Khosla, M.; Herschlag, D. Protein Enhancement of Hammerhead Ribozyme Catalysis. Science 1993, 262, 99-102.
87. Samulski, R. J. Adeno-associated virus: Integration at a Specific Chromosomal Locus. Curr. Opin. Genet. Dev. 1993, 3, 74-80.
88. Seth, P.; Rosenfeld, M.; Higginbotham, J.; Crystal, R. G. Mechanism of Enhancement of DNA Expression Consequent to Cointernalization of a Replication-Deficient Adenovirus and Unmodified Plasmid DNA. J. Virol. 1994, 933-940.
89. FitzGerald, D. J. P.; Padmanabhan, R.; Pastan, I.; Willingham, M. C. Adenovirus-induced Release of Epidermal Growth Factor and Pseudomonas Toxin into the Cytosol of KB Cells During Receptor-mediated Endocytosis. Cell 1983, 32, 607-617.
90. Seth, P.; FitzGerald, D.; Willingham, M.; Pastan, I. Pathway of Adenovirus Entry into Cells, in Virus Attachment and Entry into Cells; Colwell, R., Lonberg-Holm, K., Eds.; American Society for Microbiology: Washington, D. C., 1986.
91. Otero, M. J. and Carrasco, L. Proteins Are Co-internalized with Virion Particles During Early Infection. Virology 1987, 160, 75-80.
92. Cotten, M.; Wagner, E.; Zatloukal, K.; Phillips, S.; Curiel, D. T.; Bimstiel, M. L. High Efficiency Receptor-mediated Delivery of Small and Large 48 Kilobase Gene Constructs Using the Endosome-disruption Activity of Defective or Chemically Inac-tivated Adenovirus Particles. Proc. Natl. Acad. Sci. U. SA. 1992, 89, 6094-6098.
93. Curiel, D. T.; Agarwal, S.; Wagner, E.; Cotten, M. Adenovirus enhancement of transferrin-polylysine-mediated gene delivery. Proc. Natl. Acad. Sci. U. SA. 1991, 88, 8850-8854.
94. Gao, L.; Wagner, E.; Cotten, M.; Agarwal, S.; Harris, C.; Romer, M.; Miller, L.; Hu, P.-C.; Curiel, D. Direct In Vivo Gene Transfer to Airway Epithelium Employing Adenovirus-Polylysine-DNA Complexes. Human Gene Ther. 1993, 4, 17-24.
95. Sarver, N.; Cantin, E. M.; Chang, P. S.; Zaia, J. A.; Ladne, P. A.; Stephens, D. A.; Rossi, J. J. Ribozymes as Potential Anti-HIV-1 Therapeutic Agents. Science 1990, 247, 1222-1225.
96. Rossi, J. J.; Sarver, N. Catalytic Antisense RNA (Ribozymes): Their Potential and Use as Anti-HIV-1 Therapeutic Agents. Innovations in Antiviral Development and the Detection of Virus Infection; Block, T.; Ed.; Plenum Press: New York, 1992; pp 95-109.
97. Weerasinghe, M.; Liem, S. E.; Asad, S.; Read, S. E.; Joshi, S. Resistance to Human Immunodeficiency Virus Type 1 (HIV-1) Infection in Human CD4+ Lymphocyte-Derived Cell Lines Conferred by Using Retroviral Vectors Expressing an HIV-1 RNA-Specific Ribozyme J. Virol. 1991, 65, 5531-5534.
98. Dropulic, B.; Lin, N. H.; Martin, M. A.; Jean, K. T. Functional Characterization of a U5 Ribozyme: Intracellular Suppression of Human Immunodeficiency Virus Type I Expression. J. Virol. 1992, 66, 1432-1441.
99. Yu, M.; Ojwang, J.; Yamada, O.; Hampel, A.; Rapapport, J.; Looney, D.; Wong-Staal, F. A Hairpin Ribozyme Inhibits Expression of Diverse Strains of Human Immunodeficiency Virus type I. Proc. Natl. Acad. Sci. U. SA. 1993, 90, 6340-6344.
100. Ojwang, J. O.; Hampel, A.; Looney, D. J.; Wong-Staal, F.; Rappaport, J. Inhibition of Human Immunodeficiency Virus Type 1 Expression by a Hairpin Ribozyme. Proc. Natl. Acad. Sci. U. SA. 1992, 89, 10802-10806.
101. Sullenger, B. A.; Lee, T. C.; Smith, C. A.; Ungers, G. E.; Gilboa, E. Expression of Chimeric tRNA-driven Antisense Transcripts Renders HIV3T3 Cells Highly Resistant to Moloney Murine Leukemia Virus Replication. Mol. Cell. Biol. 1990, 10, 6512-6523.
102. Sullenger, B. A.; Gallardo, H. F.; Ungers, G. E.; Gilboa, E. Overexpression of TAR Sequences Renders Cells Resistant to Human Immunodeficiency Virus Replication. Cell 1990, 63, 601-608.
103. Jennings, P. A.; Molloy, P. L. Inhibition of SV40 Replicon Function by Engineered Antisense RNA Transcribed by RNA Polymerase III. EMBO J. 1987, 6, 3043-3047.
104. Myers, G.; Korber, B.; Berzofsky, J. A.; Smith, R. F.; Pavlakis, G. N. Human Retroviruses and AIDS; Theoretical Biology and Biophysics; Los Alamos, 1992.
105. Homann, M.; Tzortzakaki, S.; Rittner, K.; Sczakiel, G.; Tabler, M. Incorporation of the Catalytic Domain of a Hammerhead Ribozyme into Antisense RNA Enhances its Inhibitory Effect on the Replication of Human Immunodeficiency Virus Type 1. Nucl. Acids Res. 1993, 21, 2809-2814.
106. Bertrand, E. L.; Rossi, J. J. Facilitation of Hammerhead Ribozyme Catalysis by the Nucleocapsid Protein of HIV-1 and the Heterogeneous Nuclear Ribonucleoprotein Al. EMBO J. 1994, 13, 2904-2912.
107. Ohkawa, J.; Yuyama, T.; Nishikawa, S.; Taira, K. Importance of independence in ribozyme reactions: kinetic behavior of trimmed and of simply connected multiple ribozymes with potential activity against human immunodeficiency virus. Proc. Natl. Acad. Sci. U. SA. 1993, 90, 11302-11306.
108. Chen, C.-J.; Banerjea, A. C.; Harmison, G. G.; Haglund, K.; Schubert, M. Multitarget-ribozyme Directed to Cleave at up to Nine Highly Conserved Hiv-1 Env RNA Regions Inhibits HIV-1 Replication - Potential Effectiveness Against Most Presently Sequenced Hiv-1 Isolates. Nucl. Acids Res. 1992, 20, 4581-4589.
109. Lo, K. M. S.; Biasolo, M. A.; Dehni, G.; Palu, G.; Haseltine, W. A. Inhibition of Replication of HIV-1 by Retroviral Vectors Expressing tat-Antisense and Anti-tat Ribozyme RNA. Virology 1992, 190, 176-183.
110. Xing, Z.; Whitton, J. L. Ribozymes Which Cleave Arenavirus RNAs: Identification of Susceptible Target Sites and Inhibition by Target Site Secondary Structure. J. Virol. 1992, 66, 1361-1369.
111. Xing, Z.; Whitton, J. L. An Anti-Lymphocytic Choriomeningitis Virus Ribozyme Expressed in Tissue Culture Cells Diminishes Viral RNA Levels and Leads to a Reduction in Infectious Virus Yield. J. Virol. 1993, 67, 1840-1847.
112. Monia, B. P.; Johnston, J. F.; Ecker, D. J.; Zounes, M. A.; Lima, W. F.; Frier, S. M. Selective Inhibition of Mutant Ha-ras messenger RNA Expression by Antisense Oligonucleotides. J. Biol. Chem. 1992, 267, 19954-19962.
113. Kashani-Sabet, M.; Funato, T.; Tone, T.; Jiao, L.; Wang, W.; Yoshida, E.; Kashfinn, B. I.; Shitara, T.; Wu, A. M.; Moreno, J. G.; Traweek, S. T.; Ahlering, T. E.; Scanlon, K. J. Reversal of the Malignant Phenotype by an Anti-ras Ribozyme. Antisense Res. Dev. 1992, 2, 3-15.
114. Koizumi, M.; Kamiya, H.; Ohtsuka, E. Ribozymes Designed to Inhibit Transformation of NIH3T3 Cells by the Activated c-Ha-ras Gene. Gene 1992, 117, 179-184.
115. Koizumi, M.; Kamiya, H.; Ohtsuka, E. Inhibition of c-Ha-ras Gene Expression by hammerhead ribozymes containing a Stable C (UUCG) G Hairpin Loop. Biol. Pharm. Bull. 1993, 16, 879-883.
116. Scanlon, K. J.; Jiao, L.; Funato, T.; Wang, W.; Tone, T.; Rossi, J. J.; and Kashani-Sabet. Ribozyme-mediated cleavage of c-fos mRNA reduces gene expression of DNA synthesis enzymes and metallothionein. Proc. Natl. Acad. Sci. U. SA. 1991, 88, 10591-10595.
117. Kashani-Sabet, M.; Wang, M.; Scanlon, K. J. Cyclosporin A Suppresses Cisplatin-induced c-fos gene Expression in Ovarian Carcinoma Cells. J. Biol. Chem. 1990, 265, 11285-11288.
118. Rauscher, F. J., III; Cohen, D. R.; Curran, T.; Bos, V. J.; Vogt, P. K.; Bohmann, D.; Tjian, T.; Franza, B. R., Jr.; Cyclosporin A Suppresses Cisplatin-induced c-fos Gene Expression in Ovarian Carcinoma Cells. Science 1988, 240, 1010-1016.
119. Funato, R.; Yoshida, E.; Jiao, L.; Tone, T.; Kashani-Sabet, M.; Scanlon, K. J. The Utility of An Anti-fos Ribozyme in Reversing Cisplatin Resistance in Human Carcinomas. Adv. Enzyme Regul. 1992, 32, 195-209.
120. Snyder, D. S.; Wu, Y.; Wang, J. L.; Rossi, J. J.; Swiderski, P.; Kaplan, B. E.; Forman, S. J. Ribozyme-mediated Inhibition of bcr-abl Gene Expression in a Philadelphia Chromosome-Positive Cell Line. Blood 1993, 82, 600-605.
121. Heisterkamp, N.; Stephenson, J. R.; Groffen, J.; Hansen, P. F.; De Klein, A.; Baartram, C. R.; Grosveld, G. Localization of the c-abl Oncogene Adjacent to a translocation Break Point in Chronic Myelocytic Leukaemia. Nature 1983, 306, 239.
122. Bartram, C. R.; De Klein, A.; Hagemeijer, A.; van Agthoven, T.; van Kessel, A. G.; Bootsma, D.; Grosveld, G.; Ferguson-Smith, M. A.; Davies, T.; Stone, M.; Heisterkamp, N.; Stephenson, J. R.; Groffen, J. Translocation of c-abl Oncogene Correlates with the Presence of a Philadelphia Chromosome in Chronic Myelotic Leukaemia. Nature 1983, 306, 277.
123. Wright, L.; Wilson, S. B.; Milliken, S.; Biggs, J.; Kearney, P. Ribozyme-mediated cleavage of the bcr/abl transcript expressed in chronic myeloid leukemia. Exp. Hematol. 1993, 21, 1712-1718.
124. 210 Protein-kinase Activity. Oncogene 1993, 8, 3183-3188.
125. Cantor, G. H.; McElwain, T. F.; Birkebak, T. A.; Palmer, G. H. Ribozyme Cleaves rex/tax mRNA and Inhibits Bovine Leukemia Virus Expression. Proc. Natl. Acad. Sci. U. SA. 1993, 90, 10932-10936.
126. Woolf, T. M.; Melton, D. A.; Jennings, C. G. B. Specificity of Antisense Oligonucleotides In Vivo. Proc. Natl. Acad. Sci. U. SA. 1992, 89, 7305-7309.
127. Torrence, P. F.; Maitra, R. K.; Lesiak, K.; Khamnei, S.; Zhou, A.; Silverman, R. H. Targeting RNA for Degradation with a (2′-5′) oligoadenylate-antisense Chimera. Proc. Natl. Acad. Sci. U. SA. 1993, 90, 1300-1304.
128. Maran, A.; Maitra, R. K.; Kumar, A.; Dong, B.; Xiao, W.; Li, G.; Williams, B. R. G.; Torrence, P. F.; Silverman, R. H. Blockage of NF-κB Signaling by Selective Ablation of an mRNA Target by 2-5A Antisense chimeras. Science 1994, 265, 789-792.
129. Goodchild, J.; Kohli, V. Ribozymes That Cleave An RNA Sequence from Human Immunodeficiency Virus: the Effect of Flanking Sequence on Rate. Arch. Biochem. Biophys. 1991, 284, 386-391.
130. Taylor, N. R.; Rossi, J. J. Ribozyme-mediated Cleavage of an HIV-1 gag RNA: The Effects of Nontargeted Sequences and Secondary Structure on Ribozyme Cleavage Activity. Antisense Res. Devel. 1991, 1, 173-186.
131. Chowrira, B. M.; Pavco, P. A.; McSwiggen, J. A. In vitro and in vivo Comparison of Hammerhead, Hairpin and Hepatitis Delta Virus Self-processing Ribozyme Cassettes. J. Biol. Chem. 1994, 269, 25856-25864.